BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12228281)

  • 1. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection.
    Garg N; Tarleton RL
    Infect Immun; 2002 Oct; 70(10):5547-55. PubMed ID: 12228281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease.
    Silveira EL; Claser C; Haolla FA; Zanella LG; Rodrigues MM
    Clin Vaccine Immunol; 2008 Aug; 15(8):1292-300. PubMed ID: 18579696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.
    Gupta S; Garg NJ
    PLoS Negl Trop Dis; 2010 Aug; 4(8):e797. PubMed ID: 20706586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy.
    Katae M; Miyahira Y; Takeda K; Matsuda H; Yagita H; Okumura K; Takeuchi T; Kamiyama T; Ohwada A; Fukuchi Y; Aoki T
    Infect Immun; 2002 Sep; 70(9):4833-40. PubMed ID: 12183527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene.
    Fujimura AE; Kinoshita SS; Pereira-Chioccola VL; Rodrigues MM
    Infect Immun; 2001 Sep; 69(9):5477-86. PubMed ID: 11500420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection.
    Wizel B; Garg N; Tarleton RL
    Infect Immun; 1998 Nov; 66(11):5073-81. PubMed ID: 9784506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice.
    Costa F; Franchin G; Pereira-Chioccola VL; Ribeirão M; Schenkman S; Rodrigues MM
    Vaccine; 1998 May; 16(8):768-74. PubMed ID: 9627933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and trans-sialidase.
    Vasconcelos JR; Hiyane MI; Marinho CR; Claser C; Machado AM; Gazzinelli RT; Bruña-Romero O; Alvarez JM; Boscardin SB; Rodrigues MM
    Hum Gene Ther; 2004 Sep; 15(9):878-86. PubMed ID: 15353042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection.
    Fralish BH; Tarleton RL
    Vaccine; 2003 Jun; 21(21-22):3070-80. PubMed ID: 12798651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of antibody and protective immune responses against Trypanosoma cruzi infection elicited by immunization with a parasite antigen delivered as naked DNA or recombinant protein.
    Pereira-Chioccola VL; Costa F; Ribeirão M; Soares IS; Arena F; Schenkman S; Rodrigues MM
    Parasite Immunol; 1999 Feb; 21(2):103-10. PubMed ID: 10101720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
    Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
    J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruzi.
    Eickhoff CS; Vasconcelos JR; Sullivan NL; Blazevic A; Bruna-Romero O; Rodrigues MM; Hoft DF
    PLoS Negl Trop Dis; 2011 Mar; 5(3):e983. PubMed ID: 21408124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic immunization based on the ubiquitin-fusion degradation pathway against Trypanosoma cruzi.
    Chou B; Hiromatsu K; Hisaeda H; Duan X; Imai T; Murata S; Tanaka K; Himeno K
    Biochem Biophys Res Commun; 2010 Feb; 392(3):277-82. PubMed ID: 20059980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in mice.
    Bhatia V; Garg NJ
    Clin Vaccine Immunol; 2008 Aug; 15(8):1158-64. PubMed ID: 18550728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulatory Effects of an Immunodominant Parasite Antigen Paradoxically Prevent Induction of Optimal CD8 T Cell Protective Immunity.
    Eickhoff CS; Zhang X; Vasconcelos JR; Motz RG; Sullivan NL; O'Shea K; Pozzi N; Gohara DW; Blase JR; Di Cera E; Hoft DF
    PLoS Pathog; 2016 Sep; 12(9):e1005896. PubMed ID: 27642757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infection.
    Boscardin SB; Kinoshita SS; Fujimura AE; Rodrigues MM
    Infect Immun; 2003 May; 71(5):2744-57. PubMed ID: 12704149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
    Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
    Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Delivery of antigenic candidates by a DNA/MVA heterologous approach elicits effector CD8(+)T cell mediated immunity against Trypanosoma cruzi.
    Gupta S; Garg NJ
    Vaccine; 2012 Nov; 30(50):7179-86. PubMed ID: 23079191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma cruzi 80 kDa prolyl oligopeptidase (Tc80) as a novel immunogen for Chagas disease vaccine.
    Bivona AE; Sánchez Alberti A; Matos MN; Cerny N; Cardoso AC; Morales C; González G; Cazorla SI; Malchiodi EL
    PLoS Negl Trop Dis; 2018 Mar; 12(3):e0006384. PubMed ID: 29601585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant effect of the Propionibacterium acnes and its purified soluble polysaccharide on the immunization with plasmidial DNA containing a Trypanosoma cruzi gene.
    Mussalem JS; Vasconcelos JR; Squaiella CC; Ananias RZ; Braga EG; Rodrigues MM; Longo-Maugéri IM
    Microbiol Immunol; 2006; 50(4):253-63. PubMed ID: 16625047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.